Non-childbearing potential
Showing 1 - 25 of >10,000
Healthy Trial in Edegem (BI 765845, Placebo)
Completed
- Healthy
- BI 765845
- Placebo
-
Edegem, BelgiumSGS Life Science Services - Clinical Research
Nov 27, 2023
Healthy Volunteers Trial in Nottingham ([14C]-GDC-9545, GDC-9545 Solution for Infusion, GDC-9545/F12 Capsule)
Completed
- Healthy Volunteers
- [14C]-GDC-9545
- +3 more
-
Nottingham, United KingdomQuotient Sciences
Jan 17, 2023
Healthy Trial in Mannheim (BI 1819479, BI matching )
Recruiting
- Healthy
- BI 1819479
- BI matching placebo
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Aug 5, 2022
Healthy Female Participants Trial in Brooklyn (Zibotentan, EE/LNG)
Not yet recruiting
- Healthy Female Participants
-
Brooklyn, MarylandResearch Site
Aug 16, 2022
Metabolic Disorders, Non-alcoholic Steatohepatitis Trial in Glendale (AZD2693, Placebo)
Completed
- Metabolic Disorders
- Non-alcoholic Steatohepatitis
- AZD2693
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 24, 2021
Overweight, Obesity Trial in Montreal (NNC0174-0833, Oral contraceptive (OC) tablets, Acetaminophen)
Completed
- Overweight
- Obesity
- NNC0174-0833
- +2 more
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Jan 6, 2022
Healthy Volunteers Trial in Daytona Beach (GDC-9545 Tablet, Fasted: Treatment A, GDC-9545 Capsule, Fasted: Treatment B, GDC-9545
Completed
- Healthy Volunteers
- GDC-9545 Tablet, Fasted: Treatment A
- +2 more
-
Daytona Beach, FloridaCovance Research Unit - Daytona
Apr 1, 2021
Healthy Volunteers Trial in Daytona Beach, Dallas (GDC-0134 F09 Formulation, GDC-0134 F15 Formulation, GDC-0134 F16 Formulation)
Completed
- Healthy Volunteers
- GDC-0134 F09 Formulation
- +2 more
-
Daytona Beach, Florida
- +1 more
Aug 24, 2020
Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)
Not yet recruiting
- Healthy Women of Child Bearing Potential
- R21/Matrix-M1
- +2 more
- (no location specified)
Oct 10, 2023
Infertility, Female, Deferred Childbearing Trial in Chicago (Investigational Oocyte Cryopreservation)
Recruiting
- Infertility, Female
- Deferred Childbearing
- Investigational Oocyte Cryopreservation
-
Chicago, IllinoisUniversity of Illinois Hospital & Health Sciences System - IVF P
Nov 1, 2022
Non-Genital Warts Trial (garlic extract (15%) solution, topical chlorhexidine (2%) solution, Saline)
Not yet recruiting
- Non-Genital Warts
- garlic extract (15%) solution
- +2 more
- (no location specified)
Oct 13, 2023
Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic
Completed
- Heart Failure With Reduced Ejection Fraction
-
Seoul, Korea, Republic ofSeverance hospital
Jul 31, 2023
Healthy Participants Trial in Cypress (BMS-986166, Oral contraceptive)
Completed
- Healthy Participants
- BMS-986166
- Oral contraceptive
-
Cypress, CaliforniaWest Coast Clinical Trials Global
Mar 7, 2022
Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)
Completed
- Abuse Potential
- Placebo
- +4 more
-
Overland Park, KansasAltasciences Clinical Kansas
Oct 19, 2023
Long Non-coding RNA in Process of Epithelial-mesenchymal
Active, not recruiting
- Periodontal Disease, AVDC Stage 3and 4
- +2 more
- periodontitis challenge
-
Baghdad, Iraqsaif mohammed T AL Mufti
Aug 8, 2023
Healthy Non-dependent, Recreational Sedative Users, Abuse Potential Trial in Overland Park, Montreal (Suvorexant, Zolpidem,
Recruiting
- Healthy Non-dependent, Recreational Sedative Users
- Abuse Potential
- Suvorexant
- +3 more
-
Overland Park, Kansas
- +1 more
Jan 31, 2023
The Long Non Coding MALAT1 asPotential Salivary Diagnostic
Completed
- Oral Cancer Biomarkers
-
Giza, EgyptRania Hassan Shalby
Jan 31, 2023
Abuse Potential Trial in Salt Lake City (gabapentin 600 mg, gabapentin 1200 mg, gabapentin 1800 mg)
Completed
- Abuse Potential
- gabapentin 600 mg
- +4 more
-
Salt Lake City, UtahPharmaceutical Research Associates, Inc.
Dec 22, 2022
NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Non-small Cell Lung Cancer
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Jun 27, 2023
Prognostic Immune Biomarkers in HNSCC
Completed
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Tumour immunoprofile evaluation
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Jul 3, 2023